Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections
Document Type
Article
Department
Gastroenterology; Medicine
Abstract
End-stage liver disease (ESLD) is a life-threatening clinical syndrome and when complicated with infection the mortality is markedly increased. In patients with ESLD, bacterial or fungal infection can induce or aggravate the occurrence or progression of liver decompensation. Consequently, infections are among the most common complications of disease deterioration. There is an overwhelming need for standardized protocols for early diagnosis and appropriate management for patients with ESLD complicated by infections. Asia Pacific region has the largest number of ESLD patients, due to hepatitis B and the growing population of alcohol and NAFLD. Concomitant infections not only add to organ failure and high mortality but also to financial and healthcare burdens. This consensus document assembled up-to-date knowledge and experience from colleagues across the Asia-Pacific region, providing data on the principles as well as evidence-based current working protocols and practices for the diagnosis and treatment of patients with ESLD complicated by infections.
Publication (Name of Journal)
Hepatology International
DOI
10.1007/s12072-023-10637-3
Recommended Citation
Chen, T.,
Chen, G.,
Wang, G.,
Treeprasertsuk, S.,
Lesmana, C. A.,
Lin, H.,
Al-Mahtab, M.,
Chawla, Y. K.,
Jafri, W.,
Hamid, S.
(2024). Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections. Hepatology International.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_med_gastroenterol/345
Comments
Volume, issue and pagination are not provided by the author/publisher.